Eli Lilly and Co (LLY)
111.35
-1.18 -1.05%
NYSE
Aug 20, 14:26
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 23.23B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 7.934 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 7.843B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 80.04% |
| Profit Margin (Quarterly) | 23.55% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 107.50B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.741 |
| PE Ratio (TTM) | 14.03 |
| Price to Book Value | 38.66 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 766.20M |
| Return on Equity (TTM) | Upgrade |
View All LLY News
News
-
WireHeadlineTime (ET)
-
Yahoo08/20 11:03
-
Yahoo08/19 17:44
-
PR Newswire08/19 16:15
-
Yahoo08/19 11:05
-
Yahoo08/19 10:29
-
SA Breaking News08/19 06:53
-
Yahoo08/18 07:28
-
Yahoo08/16 16:25
-
SA Breaking News08/16 12:36
-
Yahoo08/16 11:28
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 02/13/2020 09:00 EST | Misc | Eli Lilly and Co Fourth Quarter Earnings Conference Call in 2019 |
| 02/13/2020 | Earnings | Eli Lilly and Co Fourth Quarter Earnings in 2019 Release |
| 10/23/2019 09:00 EDT | Misc | Eli Lilly and Co Third Quarter Earnings Conference Call in 2019 |
| 10/23/2019 | Earnings | Eli Lilly and Co Third Quarter Earnings Results in 2019 |
| 08/14/2019 | Dividends | Amount: 0.645, Declared Date: Jun 19 2019, Pay Date: Sep 10 2019 |
| 07/30/2019 09:00 EDT | Misc | Eli Lilly and Co Second Quarter Earnings Conference Call in 2019 |
| 07/30/2019 | Earnings | Eli Lilly and Co Second Quarter Earnings Results in 2019 |
| 05/16/2019 | Dividends | Amount: 0.645, Declared Date: May 06 2019, Pay Date: Jun 10 2019 |
| 05/06/2019 11:00 EDT | Misc | Eli Lilly and Co Annual General Meeting in 2018 |
| 04/30/2019 09:00 EDT | Misc | Eli Lilly and Co First Quarter Earnings Conference Call in 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.lilly.com
- Investor Relations URL: https://investor.lilly.com/
- HQ State/Province: Indiana
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Blend
- Next Earnings Release: Oct. 23, 2019
- Last Earnings Release: Jul. 30, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Aug. 14, 2019
- Description: Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 111.35 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| VPMCX | Vanguard PRIMECAP Inv | 3.91% |
| VHCOX | Vanguard Capital Opportunity Inv | 3.61% |
| VGHCX | Vanguard Health Care Inv | 3.33% |
| VPCCX | Vanguard PRIMECAP Core Inv | 3.26% |
| XLV | Health Care Select Sector SPDR® ETF | 2.82% |
| IYH | iShares US Healthcare ETF | 2.60% |
| POGRX | PRIMECAP Odyssey Growth | 2.52% |
| VHT | Vanguard Health Care ETF | 2.39% |
| FTCS | First Trust Capital Strength ETF | 2.13% |
| IXJ | iShares Global Healthcare ETF | 1.93% |
| MTUM | iShares Edge MSCI USA Momentum Fctr ETF | 1.39% |
| VEIPX | Vanguard Equity-Income Inv | 1.21% |
Excel Add-In Codes
- Name: =YCI("LLY","name")
- Description: =YCI("LLY","description")
- Sector: =YCI("LLY","sector")
- Industry: =YCI("LLY","industry")
- Est. Current Fiscal Year End: =YCI("LLY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- LLY Tweets Stocktwits
Advertisement
